C57BL/6J mouse Metagenome
收藏NIAID Data Ecosystem2026-05-26 收录
官方服务：
资源简介：
This study assessed the impact of 2 anti-diabetic therapies on the gut microbiome and markers of cardiometabolic disease risk in mice. Diet-induced obese and diabetic C57BL/6J mice were treated with 1 of 2 antidiabetic therapeuticsâmetformin or a DPP-4 inhibitor (PKF-275-055) for 12 weeks.
创建时间：
2018-10-24
